Heart Failure With Preserved Ejection Fraction (HFPEF) Clinical Trial
— PREFFORTOfficial title:
Evaluation of Left Ventricular Filling Pressures During Exercise: Comparative Study, Catheterization Versus Echocardiography
Heart failure with preserved ejection fraction (HFPEF) is common and is a real public health
issue. Diagnosis, especially when there are no congestive signs, is difficult. It has been
shown that many patients with suspected HFPEF had left ventricular (LV) filling pressures
elevated only at exercise (normal at rest).
Using stress echocardiography and taking into account left atrial (LA) remodeling at rest as
a "memory" of chronic elevation of filling pressures. We believe that it is possible to
improve the noninvasive diagnosis of exercise elevation of the LV end-diastolic pressure
(LVEDP).
Status | Completed |
Enrollment | 60 |
Est. completion date | September 2013 |
Est. primary completion date | September 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients hospitalized for coronary angiography - Sinus Rhythm - Left ventricular Ejection Fraction > 50% Exclusion Criteria: - Age < 18years - Hypertrophic Cardiomyopathy - Cardiac transplantation - Mitral stenosis - Mitral insufficiency >2/4 - Severe calcification of mitral annulus - Mitral prothesis or mitral repair - aortic prothesis - Severe aortic stenosis - Atrial fibrillation - Acute coronary syndrom < 3 months - Left ventricular thrombus - Severe renal Failure - failure of radial way for coronary angiography - coronary lesion indicating an angioplasty - impossibility to perform an exercise - refusal or inability to sign informed consent - no French medical insurance |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
France | Pitié Salpêtrière Hospital - Cardiology Department | Paris |
Lead Sponsor | Collaborator |
---|---|
French Cardiology Society | French Federation of Cardiology |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | E/Ea ratio | E/Ea ratio as a non-invasive index of Left Ventricular and diastolic pressure (LVEDP) at exercise | Day 1 | No |
Secondary | left atrial (LA) morphology | To evaluate left atrial (LA) morphology at rest (maximal LA volume indexed to body area, maximal LA volume to maximal LV volume ratio) as an index of Left Ventricular end diastolic pressure (LVEDP) at exercise. | Day 1 | No |
Secondary | LA function at rest | To evaluate LA function at rest (distensibility, global longitudinal strain) as an index of Left Ventricular end diastolic pressure (LVEDP) at exercise. | Day 1 | No |
Secondary | E/Ea ratio at exercise with LA remodeling indices at rest | To investigate whether the combined use of E/Ea ratio at exercise with LA remodeling indices at rest (of morphology and/or function) improves the performance characteristics of diagnostic test compared to a separate use of these parameters. | Day 1 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Recruiting |
NCT05441839 -
UK Heart Failure With Preserved Ejection Fraction
|
||
Completed |
NCT01989299 -
Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients With Heart Failure and Preserved Ejection Fraction
|
||
Terminated |
NCT03909295 -
An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.
|
Phase 3 | |
Completed |
NCT04327024 -
Study of Verinurad in Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Active, not recruiting |
NCT05136820 -
Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study
|
N/A | |
Completed |
NCT03988634 -
Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)
|
Phase 3 | |
Recruiting |
NCT03876223 -
Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
|
||
Completed |
NCT04232345 -
A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT05792059 -
DevElopMent of Clinical PATHwaYs to the Diagnosis of Heart Failure With Preserved Ejection Fraction
|
||
Completed |
NCT03843060 -
A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT06036186 -
Study for the Treatment of Heart Failure With Preserved Ejection Fraction Associated With High Blood Pressure Using Right Atrial Pacing Controlled by the PressurePaceTM System
|
N/A | |
Recruiting |
NCT05383287 -
Characteristics, Phenotypes, and TRAITS of Heart Failure With Preserved Ejection Fraction (TRAITS-HFpEF)
|
||
Completed |
NCT03877224 -
DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fraction
|
Phase 3 | |
Active, not recruiting |
NCT04847557 -
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
|
Phase 3 | |
Recruiting |
NCT04822649 -
Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition
|
N/A |